Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules targeting central nervous system disorders. Its structure enables incorporation into more complex molecules where the difluoroazetidine moiety enhances metabolic stability and membrane permeability. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties, especially in the design of enzyme inhibitors and receptor modulators. Also utilized in the preparation of novel analogs for structure-activity relationship studies due to its compact, polar nature and favorable hydrogen bonding capacity.